Insight Molecular Diagnostics

IMDX

Börsenwert 92,6 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Broadwood Capital New York	18,2 Mio. $	+2,45 Mio. $	+21.250	+16 %
2	AG 2 Artal Group Luxembourg	893.000 $	+495.989 $	+4.295	+134 %
3	3 Bridgeway Capital Management Houston, Texas	866.000 $	+259.831 $	+2.250	+45 %
4	4 Vanguard Group Malvern, Pennsylvania	584.000 $	+5.197 $	+45	+0,9 %
5	MHP 5 Manatuck Hill Partners Westport, Connecticut	500.000 $	–	–	–
6	6 BlackRock New York	485.000 $	+470.583 $	+4.075	Neu
7	7 Goldman Sachs New York	219.000 $	+212.253 $	+1.838	Neu
8	8 Destination Wealth Management Walnut Creek, California	176.000 $	–	–	–
9	9 Millennium Management New York	157.000 $	+152.088 $	+1.317	Neu
10	10 Family Management New York	97.000 $	+25.175 $	+218	+36 %
11	11 Geode Capital Management Boston, Massachusetts	89.000 $	–	–	–
12	12 Susquehanna International Group Bala Cynwyd, Pennsylvania	74.000 $	+72.175 $	+625	Neu
13	13 Bank of New York Mellon New York	63.000 $	+61.089 $	+529	Neu
14	14 PNC Financial Services Group Pittsburgh, Pennsylvania	24.000 $	–	–	–
15	15 Morgan Stanley New York	19.000 $	+12.010 $	+104	+182 %
16	16 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	6.000 $	–	–	–
17	17 Barclays London, United Kingdom	6.000 $	+6.120 $	+53	Neu
18	18 Carroll Financial Associates Charlotte, North Carolina	5.000 $	–	–	–
19	19 Tower Research Capital (TRC) New York	4.000 $	+4.157 $	+36	Neu
20	20 Deutsche Bank Frankfurt Am Main Ge, Germany	4.000 $	+4.504 $	+39	+3.900 %
21	21 Royal Bank of Canada Toronto, Ontario, Canada	3.000 $	+1.848 $	+16	+133 %
22	22 Bank of America Charlotte, North Carolina	2.000 $	-1.155 $	-10	-43 %
23	23 MUFG Americas New York	2.000 $	–	–	–
24	24 UBS Group Zurich, Switzerland	1.000 $	-3.464 $	-30	-86 %
25	25 Creative Planning Overland Park, Kansas	1.000 $	–	–	–

Insight Molecular Diagnostics IMDX Börsenwert 92,6 Mio. $

Insight Molecular Diagnostics

IMDX

Börsenwert 92,6 Mio. $